Do you want to read an article? Please log in or register.
Therapy of Psoriasis Arthritis Taking into Account New Treatment Options
Psoriatic Arthritis
Related content
COMMENTED
PsoriasisRheumatoid Arthritis
Anti-tumour necrosis factor-α therapy and recurrent or new primary cancers in patients with inflammatory bowel disease, rheumatoid arthritis, or psoriasis and previous cancer in Denmark: a nationwide, population-based cohort study
★ 3
Recommended and commented by
Dr Heino Prillwitz, Faculty Member
★ 3
Recommended and commented by
PD Dr Luc Biedermann, Faculty Member
doi: 10.1016/S2468-1253(19)30362-0.
PsoriasisRheumatoid Arthritis
Tofacitinib in the Treatment of Rheumatoid Arthritis and Chronic Plaque Psoriasis.
Skin Therapy Lett.
Gupta AK, Cernea M, Lynde CW
Psoriatic Arthritis
2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis
Arthritis Rheumatol.
Singh JA, Guyatt G, Ogdie A, Gladman DD, Deal C, Deodhar A, Dubreuil M, Dunham J, Husni ME, Kenny S, Kwan-Morley J, Lin J, Marchetta P, Mease PJ, Merola JF, Miner J, Ritchlin CT, Siaton B, Smith BJ, Van Voorhees AS, Jonsson AH, Shah AA, Sullivan N, Turgunbaev M, Coates LC, Gottlieb A, Magrey M, Nowell WB, Orbai AM, Reddy SM, Scher JU, Siegel E, Siegel M, Walsh JA, Turner AS, Reston J
doi: 10.1002/art.40726.
Psoriasis
Tofacitinib: A New Oral Therapy for Psoriasis
Clin Drug Investig.
Azevedo A, Torres T
doi: 10.1007/s40261-017-0596-y.
PsoriasisPsoriatic ArthritisRheumatoid Arthritis
Tofacitinib for the treatment of psoriasis and psoriatic arthritis
Expert Rev Clin Immunol.
Berekmeri A, Mahmood F, Wittmann M, Helliwell P
doi: 10.1080/
Psoriasis
Secukinumab treatment leads to normalisation of quality of life and disease symptoms in psoriasis patients with or without prior systemic psoriasis therapy: The PROSE study results
J Eur Acad Dermatol Venereol.
Augustin M, Dauden E, Mrowietz U, Konstantinou MP, Gerdes S, Kingo K, Szepietowski JC, Perrot JL, Cuccia A, Rissler M, Gathmann S, Sieder C, Orsenigo R, Jagiello P, Bachhuber T
doi: 10.1111/jdv.16632.
Psoriatic Arthritis
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis/Outcome Measures in Rheumatology Consensus-Based Recommendations and Research Agenda for Use of Composite Measures and Treatment Targets in Psoriatic Arthritis
Arthritis Rheumatol.
Coates LC, FitzGerald O, Merola JF, Smolen J, van Mens LJJ, Bertheussen H, Boehncke WH, Callis Duffin K, Campbell W, de Wit M, Gladman D, Gottlieb A, James J, Kavanaugh A, Kristensen LE, Kvien TK, Luger T, McHugh N, Mease P, Nash P, Ogdie A, Rosen CF, Strand V, Tillett W, Veale DJ, Helliwell PS
doi: 10.1002/art.40391.
Psoriasis
Depressive symptoms, depression, and the effect of biologic therapy among patients in Psoriasis Longitudinal Assessment and Registry (PSOLAR)
J Am Acad Dermatol.
Strober B, Gooderham M, de Jong EMGJ, Kimball AB, Langley RG, Lakdawala N, Goyal K, Lawson F, Langholff W, Hopkins L, Fakharzadeh S, Srivastava B, Menter A
doi: 10.1016/j.jaad.2017.08.051.
Psoriatic Arthritis
Efficacy of new treatments for dactylitis of psoriatic arthritis: update of literature review
Clin Rheumatol.
Sondag M, Verhoeven F, Guillot X, Prati C, Wendling D
doi: 10.1007/s10067-